Synodic Lifesciences Profile
Key Indicators
- Authorised Capital ₹ 1.00 M
- Paid Up Capital ₹ 0.10 M
- Company Age 4 Year, 1 Month
- Last Filing with ROC 31 Mar 2023
- Open Charges ₹ 2.00 M
- Revenue Growth 95.63%
- Profit Growth 99.48%
- Ebitda -50.34%
- Net Worth 111.55%
- Total Assets 29.52%
About Synodic Lifesciences
Synodic Lifesciences Private Limited (SLPL) is a Private Limited Indian Non-Government Company incorporated in India on 04 January 2021 (Four years and one month 17 days old ). Its registered office is in Indore, Madhya Pradesh, India.
The Company is engaged in the Healthcare Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 1.00 M and a paid-up capital of Rs 0.10 M.
The company currently has active open charges totaling ₹2.00 M.
Manoj Patidar, Yashwant Chouhan, and Govind Sharma serve as directors at the Company.
Company Details
- Location
Indore, Madhya Pradesh, India
- Telephone
+91-XXXXXXXXXX
- Email Address
- Website
-
- Social Media -
Corporate Identity Details
- CIN/LLPIN
U24290MP2021PTC054369
- Company No.
054369
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
04 Jan 2021
- Date of AGM
30 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Gwalior
Industry
Who are the key members and board of directors at Synodic Lifesciences?
Board Members (3)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Manoj Patidar  | Director | 30-Sep-2021 | Current |
| Yashwant Chouhan | Director | 30-Sep-2021 | Current |
| Govind Sharma | Director | 30-Sep-2021 | Current |
Financial Performance of Synodic Lifesciences.
Synodic Lifesciences Private Limited, for the financial year ended 2023, experienced significant growth in revenue, with a 95.63% increase. The company also saw a substantial improvement in profitability, with a 99.48% increase in profit. The company's net worth Soared by an impressive increase of 111.55%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Synodic Lifesciences?
Unlock access to Synodic Lifesciences's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Charges (Loans)
₹2.00 M
₹0
Charges Breakdown by Lending Institutions
- Hdfc Bank Limited : 0.20 Cr
Latest Charge Details
| Date | Lender | Amount | Status |
|---|---|---|---|
| 23 May 2023 | Hdfc Bank Limited | ₹2.00 M | Open |
How Many Employees Work at Synodic Lifesciences?
Synodic Lifesciences has a workforce of 0 employees as of Apr 03, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Synodic Lifesciences, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Synodic Lifesciences's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
_PRIVATE_LIMITED_354462.webp){kind=small}
